Cargando…
COVID-19-Associated Encephalopathy—Case Series and Clinical Considerations
Neurological manifestations of the SARS-CoV-2 infection are present in up to 80% of the affected patients. While the majority of them is benign, in certain patients, viral replication in the central nervous system results in a severe disruption in cognitive function as well as basic life functions....
Autores principales: | Udzik, Jakub, Jakubowski, Paweł, Niekrasz, Małgorzata, Barczyszyn, Adrian, Parczewski, Miłosz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874868/ https://www.ncbi.nlm.nih.gov/pubmed/35207253 http://dx.doi.org/10.3390/jcm11040981 |
Ejemplares similares
-
Neurological Manifestations of Non-Severe COVID-19—A Multidirectional Approach
por: Udzik, Jakub, et al.
Publicado: (2023) -
Tocilizumab Use among Patients Who Developed Pulmonary Embolism in the Course of Cytokine Release Storm and COVID-19 Pneumonia—A Retrospective Study
por: Chober, Daniel, et al.
Publicado: (2022) -
Clinical, cerebrospinal fluid, and neuroimaging findings in COVID-19 encephalopathy: a case series
por: Tuma, Raphael L., et al.
Publicado: (2021) -
COVID-19-associated neurological sequelae: A case series on cerebral microbleeds and encephalopathy
por: Safan, Abeer Sabry, et al.
Publicado: (2023) -
Electroencephalographic (EEG) features of encephalopathy in the setting of Covid-19: A case series
por: Canham, L.J.W., et al.
Publicado: (2020)